• 1. Enabling stable MnO2 matrix for aqueous zinc-ion battery cathodes?
  Yiding Jiao,Liqun Kang,Jasper Berry-Gair,Kit McColl,Jianwei Li,Haobo Dong,Hao Jiang,Ryan Wang,Furio Corà,Dan J. L. Brett,Ivan P. Parkin J. Mater. Chem. A, 2020,8, 22075-22082
• 2. Exceptional activity of sub-nm Pt clusters on CdS for photocatalytic hydrogen production: a combined experimental and first-principles study?
  Qiyuan Wu,Shangmin Xiong,Peichuan Shen,Shen Zhao,Alexander Orlov Catal. Sci. Technol., 2015,5, 2059-2064
• 3. Excellent mechanical performance and enhanced dielectric properties of OBC/SiO2 elastomeric nanocomposites: effect of dispersion of the SiO2 nanoparticles?
  Xing Zhao,Lu Bai,Rui-Ying Bao,Zheng-Ying Liu,Ming-Bo Yang,Wei Yang RSC Adv., 2017,7, 46297-46305
• 4. Empowering microfluidics by micro-3D printing and solution-based mineral coating?
  Hongxia Li,Aikifa Raza,Qiaoyu Ge,Jin-You Lu,TieJun Zhang Soft Matter, 2020,16, 6841-6849
• 5. Emerging investigator series: heterogeneous reactions of sulfur dioxide on mineral dust nanoparticles: from single component to mixed components?
  Tao Wang,Yangyang Liu,Yue Deng,Hongbo Fu,Jianmin Chen Environ. Sci.: Nano, 2018,5, 1821-1833

• Solvents and Organic Chemicals Organic Compounds Lipids and lipid-like molecules Fatty Acyls Fatty acids and conjugates Halogenated fatty acids

Introduction to 2-ethyl-4,4,4-trifluorobutanoic acid (CAS No. 769169-19-9)

2-ethyl-4,4,4-trifluorobutanoic acid, identified by the Chemical Abstracts Service Number (CAS No.) 769169-19-9, is a fluorinated carboxylic acid that has garnered significant attention in the field of pharmaceutical and chemical research due to its unique structural properties and potential applications. This compound belongs to a class of molecules that incorporate fluorine atoms, which are known to influence the metabolic stability, bioavailability, and overall efficacy of drug candidates. The presence of multiple fluorine substituents in the molecule enhances its lipophilicity and metabolic resistance, making it a valuable building block in the synthesis of novel therapeutic agents.

The chemical structure of 2-ethyl-4,4,4-trifluorobutanoic acid consists of a four-carbon chain with an ethyl group at the second carbon and three fluorine atoms at the fourth carbon. This arrangement imparts a high degree of steric hindrance and electronic effects that can be exploited in drug design. The carboxylic acid functional group at one end of the molecule allows for further derivatization, enabling the synthesis of esters, amides, and other pharmacologically relevant derivatives. These properties make it a versatile intermediate in organic synthesis and a potential candidate for further development in medicinal chemistry.

In recent years, there has been growing interest in fluorinated compounds due to their ability to improve pharmacokinetic profiles of drugs. Studies have demonstrated that fluorine atoms can enhance binding affinity to biological targets by increasing hydrophobic interactions and reducing susceptibility to enzymatic degradation. For instance, fluoroaromatic compounds have been widely used in antiviral and anticancer drugs due to their improved bioavailability and metabolic stability. Similarly, 2-ethyl-4,4,4-trifluorobutanoic acid may offer advantages in these areas by providing a stable scaffold for drug development.

The synthesis of 2-ethyl-4,4,4-trifluorobutanoic acid typically involves multi-step organic reactions that require careful selection of reagents and conditions to ensure high yield and purity. One common approach involves the fluorination of ethyl butanoate followed by hydrolysis to yield the corresponding carboxylic acid. Advanced techniques such as catalytic hydrogenation and cross-coupling reactions may also be employed to introduce additional functional groups or modify existing ones. The use of palladium-based catalysts has been particularly effective in facilitating these transformations while maintaining high selectivity.

The potential applications of 2-ethyl-4,4,4-trifluorobutanoic acid extend beyond pharmaceuticals into other areas such as agrochemicals and materials science. In agrochemicals, fluorinated compounds are often used as intermediates in the synthesis of herbicides and pesticides due to their enhanced stability and bioactivity. The unique electronic properties of this molecule make it a promising candidate for developing novel agrochemical agents with improved environmental profiles.

In materials science, the incorporation of fluorine atoms into organic molecules can lead to materials with exceptional thermal stability and chemical resistance. 2-ethyl-4,4,4-trifluorobutanoic acid could serve as a precursor for synthesizing high-performance polymers or coatings that exhibit these desirable properties. Such materials are increasingly sought after for applications in harsh environments where conventional polymers may degrade rapidly.

The biological activity of 2-ethyl-4,4,4-trifluorobutanoic acid has been explored in several preclinical studies aimed at identifying new therapeutic targets. Initial research suggests that this compound may have inhibitory effects on certain enzymes involved in metabolic pathways relevant to inflammation and cancer. While these findings are preliminary, they highlight the potential of this molecule as a lead compound for further drug discovery efforts.

The development of novel synthetic methodologies for fluorinated compounds remains an active area of research. Advances in flow chemistry and continuous manufacturing have enabled more efficient production processes for complex molecules like 2-ethyl-4,4,4-trifluorobutanoic acid. These innovations not only improve scalability but also reduce waste generation, aligning with growing demands for sustainable chemical practices.

In conclusion, 2-ethyl-4,4,4-trifluorobutanoic acid (CAS No. 769169-19-9) is a multifaceted compound with significant potential across multiple industries. Its unique structural features make it an attractive intermediate for pharmaceutical synthesis while also offering opportunities in agrochemicals and materials science. As research continues to uncover new applications for fluorinated compounds like this one, their role in advancing technological and medical innovation is likely to expand further.

• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)